Stockreport

Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis [Yahoo! Finance]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF patients achieving clear or almost clear skin after 16 weeks and 49.6% achieving a significant reduction in psoriasis severity. The treatment was also found to be safe, [Read more]